About NIRAPARIB
Class: | PARP inhibitor
Use: | Treatment of adult patients with recurrent ovarian cancer, including those with BRCA mutation, following response to platinum-based chemotherapy
Adult dose: | 300 mg orally once daily
Pediatric dose: | Safety and efficacy not established in pediatric patients
Side effects: | Nausea, fatigue, anemia, thrombocytopenia, vomiting, constipation, abdominal pain, headache
Contraindications: | Hypersensitivity to niraparib or any component of the formulation; sev
Drug Class
PARP inhibitor
Uses & Indications
Treatment of adult patients with recurrent ovarian cancer, including those with BRCA mutation, following response to platinum-based chemotherapy
Storage Requirements
Store at 20°C to 25°C (68°F to 77°F); protect from moisture and light
Manufacturer & Packaging
Manufacturer: GlaxoSmithKline Ireland Limited, Ireland
Package Size
84'S
Price & Supplier
Price in UAE: AED 31663.80
Dosage Information
Adult Dose
300 mg orally once daily
Pediatric Dose
Safety and efficacy not established in pediatric patients
Side Effects
Nausea, fatigue, anemia, thrombocytopenia, vomiting, constipation, abdominal pain, headache
Contraindications & Precautions
Hypersensitivity to niraparib or any component of the formulation; severe thrombocytopenia or anemia prior to treatment
Important Warnings
Risk of myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML); monitor complete blood counts regularly; risk of hypertension; may cause embryo-fetal toxicity; not recommended during pregnancy or breastfeeding
Related Medicines in Same Category
See also: Other PARP inhibitor medicines available in UAE pharmacies
Olaparib
Olaparib
Olaparib
Medical Disclaimer
This information is for educational purposes only and should not replace professional medical advice.
Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication.
The information presented here is specific to medicines available in UAE pharmacies and is regularly updated
to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.